Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry|January 27, 2009
13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluationKatarzyna Plonska-Ocypa, Rafal R Sicinski, Lori A Plum, et al.
Journal of Medicinal Chemistry|April 12, 2012
A 20S combined with a 22R configuration markedly increases both in vivo and in vitro biological activity of 1α,25-dihydroxy-22-methyl-2-methylene-19-norvitamin D3Agnieszka Flores, Rafal R Sicinski, Pawel Grzywacz, et al.
The Journal of Biological Chemistry|May 2, 2002
The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibitionXiaomei Qi, Rocky Pramanik, Jintang Wang, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 2, 2005
Responsiveness of human retinoblastoma and neuroblastoma models to a non-calcemic 19-nor Vitamin D analogDaniel M Albert, Lori A Plum, William Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2002
A ligand for the aryl hydrocarbon receptor isolated from lungJiasheng Song, Margaret Clagett-Dame, Richard E Peterson, et al.
Journal of Medicinal Chemistry|August 23, 2014
Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluationSalvatore Ferla, Ahmed S Aboraia, Andrea Brancale, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2005
CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1alpha-hydroxylase promoter activity in the skinJaneen L Vanhooke, Jean M Prahl, Christine Kimmel-Jehan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 5, 2010
The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trialHector F DeLuca, Wendy Bedale, Neil Binkley, et al.
The Journal of Biological Chemistry|June 5, 2015
1,25-Dihydroxyvitamin D3 Controls a Cohort of Vitamin D Receptor Target Genes in the Proximal Intestine That Is Enriched for Calcium-regulating ComponentsSeong Min Lee, Erin M Riley, Mark B Meyer, et al.
Bioorganic & Medicinal Chemistry|June 10, 2008
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structureMasato Shimizu, Yukiko Miyamoto, Hajime Takaku, et al.
Pageof 16